Although anti-vascular endothelial growth factor (anti-VEGF) therapy for AMD is effective in reducing the activity of choroidal neovascular membrane (CNV) and resolving exudation2, it does not restore the lost or damaged retinal cells, including retinal pigment epithelial (RPE) or photoreceptor cells. Here, VEGFA is linked to age-related macular degeneration.